
Developing a transdermal formulation of an approved osteoporosis treatment.
Industry: Health Care
First Day Return: +0.1%
| IPO Date | 01/26/2015 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Fremont, CA, United States |
|---|---|
| Founded | 2007 |
| Employees at IPO | 29 |
| Website www.zosanopharma.com | |